The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | G | Genito urinary system and sex hormones | |
| 2 | G03 | Sex hormones and modulators of the genital system | |
| 3 | G03C | Estrogens | |
| 4 | G03CX | Other estrogens |
| Code | Title | |
|---|---|---|
| G03CX01 | Tibolone |
| Active Ingredient | Description | |
|---|---|---|
| Tibolone |
Tibolone is rapidly metabolised into three compounds, which all contribute to the pharmacodynamic profile of tibolone. Two of the metabolites (3α-OH-tibolone and 3β-OH-tibolone) have oestrogenic-like activities, whereas the third metabolite (4Δ-isomer of tibolone) has progestogenic and androgenic-like activities. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| TIBILIVE Tablet | Health Products Regulatory Authority (ZA) | MPI, Generic | |
| TIBOLONE Tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
